venlafaxine hydrochloride has been researched along with Akinetic-Rigid Variant of Huntington Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salanio, DM; Stanton, JED; Taylor, R; Wild, EJ | 1 |
| Deshmukh, R; Gill, JS; Jamwal, S; Kumar, P | 1 |
| Bonelli, RM; Holl, AK; Holl, EM; Painold, A; Wilkinson, L | 1 |
1 trial(s) available for venlafaxine hydrochloride and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Huntington Disease; Irritable Mood; Male; Middle Aged; Nausea; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
2 other study(ies) available for venlafaxine hydrochloride and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Ghost Pills: A Case Report.
Topics: Aged; Antidepressive Agents, Second-Generation; Anxiety; Delayed-Action Preparations; Depression; Feces; Humans; Huntington Disease; Male; Venlafaxine Hydrochloride | 2017 |
Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation.
Topics: Animals; Corpus Striatum; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; Huntington Disease; Interleukin-1beta; Interleukin-6; Lipid Peroxidation; Male; Motor Activity; Neuroprotective Agents; Neurotransmitter Agents; Oxidative Stress; Quinolinic Acid; Rats; Rats, Wistar; Rotarod Performance Test; Sertraline; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2017 |